Skip to content

Research at St Andrews

Effect on treatment adherence of distributing essential medicines at no charge: the CLEAN Meds randomized clinical trial

Research output: Contribution to journalArticle

Author(s)

Navindra Persaud, Michael Bedard, Andrew S. Boozary, Richard H. Glazier, Tara Gomes, Stephen W. Hwang, Peter Jüni, Michael R. Law, Muhammad M. Mamdani, Braden J. Manns, Danielle Martin, Steven G. Morgan, Paul I. Oh, Andrew D. Pinto, Baiju R. Shah, Frank Sullivan, Norman Umali, Kevin E. Thorpe, Karen Tu, Andreas Laupacis & 1 more for the Carefully Selected and Easily Accessible at No Charge Medicines (CLEAN Meds) Study Team

School/Research organisations

Abstract

Importance: Nonadherence to treatment with medicines is common globally, even for life-saving treatments. Cost is one important barrier to access, and only some jurisdictions provide medicines at no charge to patients.

Objective: To determine whether providing essential medicines at no charge to outpatients who reported not being able to afford medicines improves adherence.

Design, Setting, and Participants: A multicenter, unblinded, parallel, 2-group, superiority, outcomes assessor-blinded, individually randomized clinical trial conducted at 9 primary care sites in Ontario, Canada, enrolled 786 patients between June 1, 2016, and April 28, 2017, who reported cost-related nonadherence. Follow-up occurred at 12 months. The primary analysis was performed using an intention-to-treat principle.

Interventions: Patients were randomly allocated to receive free medicines on a list of essential medicines in addition to otherwise usual care (n = 395) or usual medicine access and usual care (n = 391).

Main Outcomes and Measures: The primary outcome was adherence to treatment with all medicines that were appropriately prescribed for 1 year. Secondary outcomes were hemoglobin A1c level, blood pressure, and low-density lipoprotein cholesterol levels 1 year after randomization in participants taking corresponding medicines.

Results: Among the 786 participants analyzed (439 women and 347 men; mean [SD] age, 51.7 [14.3] years), 764 completed the trial. Adherence to treatment with all medicines was higher in those randomized to receive free distribution (151 of 395 [38.2%]) compared with usual access (104 of 391 [26.6%]; difference, 11.6%; 95% CI, 4.9%-18.4%). Control of type 1 and 2 diabetes was not significantly improved by free distribution (hemoglobin A1c, -0.38%; 95% CI, -0.76% to 0.00%), systolic blood pressure was reduced (-7.2 mm Hg; 95% CI, -11.7 to -2.8 mm Hg), and low-density lipoprotein cholesterol levels were not affected (-2.3 mg/dL; 95% CI, -14.7 to 10.0 mg/dL).

Conclusions and Relevance: The distribution of essential medicines at no charge for 1 year increased adherence to treatment with medicines and improved some, but not other, disease-specific surrogate health outcomes. These findings could help inform changes to medicine access policies such as publicly funding essential medicines.

Trial Registration: ClinicalTrials.gov identifier: NCT02744963.

Close

Details

Original languageEnglish
JournalJAMA Internal Medicine
VolumeOnline First
Early online date7 Oct 2019
DOIs
Publication statusE-pub ahead of print - 7 Oct 2019

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is needed

    Treweek, S., Bevan, S., Bower, P., Briel, M., Campbell, M., Christie, J., Collett, C., Cotton, S., Devane, D., El Feky, A., Galvin, S., Gardner, H., Gillies, K., Hood, K., Jansen, J., Littleford, R., Parker, A., Ramsay, C., Restrup, L., Sullivan, F. & 7 others, Torgerson, D., Tremain, L., von Elm, E., Westmore, M., Williams, H., Williamson, P. R. & Clarke, M., 7 Jan 2020, In : Trials. 21, 9 p., 33.

    Research output: Contribution to journalArticle

  2. Drivers of the opioid crisis: An appraisal of financial conflicts of interest in clinical practice guideline panels at the peak of opioid prescribing

    Spithoff, S., Leece, P., Sullivan, F., Persaud, N., Belesiotis, P. & Steiner, L., 2020, In : PLoS ONE. 15, 1, p. e0227045

    Research output: Contribution to journalArticle

  3. Choosing Wisely Canada campaign associated with less overuse of thyroid testing: retrospective parallel cohort study

    Wintemute, K., Greiver, M., McIsaac, W., Del Giudice, M. E., Sullivan, F., Aliarzadeh, B., Kalia, S., Meaney, C., Moineddin, R. & Singer, A., 13 Nov 2019, In : Canadian Family Physician. 65, 11, p. e487-e496

    Research output: Contribution to journalArticle

  4. The "All of Us" Research Program

    Sullivan, F., McKinstry, B. & Vasishta, S., 7 Nov 2019, In : New England Journal of Medicine. 381, 19, p. 1883-1885 3 p.

    Research output: Contribution to journalLetter

  5. Opioid agonist therapy during residential treatment of opioid use disorder: cohort study on access and outcomes

    Spithoff, S., Meaney, C., Urbanoski, K., Harrington, K., Que, B., Kahan, M., Leece, P., Shehadeh, V. & Sullivan, F., 11 Oct 2019, In : Canadian Family Physician. 65, 10, p. e443-e452 10 p.

    Research output: Contribution to journalArticle

Related by journal

  1. Rapid Bacterial Whole-Genome Sequencing to Enhance Diagnostic and Public Health Microbiology

    Reuter, S., Ellington, M. J., Cartwright, E. J. P., Koeser, C. U., Toeroek, M. E., Gouliouris, T., Harris, S. R., Brown, N. M., Holden, M. T. G., Quail, M., Parkhill, J., Smith, G. P., Bentley, S. D. & Peacock, S. J., 12 Aug 2013, In : JAMA Internal Medicine. 173, 15, p. 1397-1404 8 p.

    Research output: Contribution to journalArticle

ID: 262151959

Top